Skip to Main Content

David Rimm, MD, PhD

Professor of Pathology and of Medicine (Medical Oncology); Director of Pathology Tissue Services; Director of Translational Pathology

Contact Information

David Rimm, MD, PhD

Patient Care Locations

  • Brady Memorial Laboratory
    310 Cedar Street, Ste BML 55
    New Haven, CT, 06510
  • Yale New Haven Hospital
    20 York Street, Ste East Pavilion 2-631
    New Haven, CT, 06510

Office Location

Mailing Address

  • Pathology

    310 Cedar Street, PO Box 208023

    New Haven, CT, 06520-8023

    United States

David Rimm
DownloadHi-Res Photo

Appointments

Biography

David Rimm is a Professor in the Department of Pathology at the Yale University School of Medicine. He completed an MD-PhD at Johns Hopkins University Medical School followed by a Pathology Residency at Yale and a Cytopathology Fellowship at the Medical College of Virginia. He is board certified in Anatomic Pathology and Cytopathology. At Yale since 1994, Dr. Rimm is the Director of Yale Pathology Tissue Services and the Yale Tissue Microarray Facility. He is a member of the Executive Team in Pathology and serves as the Director of Translational Pathology. His lab group focuses on quantitative pathology using the AQUA® technology invented in his lab with projects related to predicting response to therapy or recurrence or metastasis in breast and lung cancer.The technology has also been used in a series of efforts related to biospecimen science. The work is supported by grants from the NIH, BCRF, and sponsored research agreements from biopharma. He is a member of a number of correlative science committees for multi-institutional breast cancer clinical trials including SWOG, ALLTO, and TEACH.He also serves on the Molecular Oncology committee for the College of American Pathologists (CAP).He is an author of over 300 peer-reviewed papers and 8 patents.He has served on advisory boards for Amgen, Genentech, Novartis, BMS, Perkin Elmer, Dako, ACD, Biocept, OptraScan and Genoptix.He was a scientific co-founder of HistoRx, a digital pathology company (sold to Genoptix in 2012) and Metamark Genetics, a prognostic determinant company.

Education & Training

  • MD
    Johns Hopkins University (1989)
  • PhD
    Johns Hopkins University (1989)
  • Fellow
    Medical College of Virginia
  • Resident
    Yale-New Haven Hospital
  • Board Certification
    AB of Pathology, Anatomic Pathology (1995)
  • Board Certification
    AB of Pathology, Cytopathology (1996)

Honors & Recognition

AwardAwarding OrganizationDate
Lauren Ackerman LectureshipWashington University of St. Louis2008
StarwoodCommitment Award 2004Greenwich Breast Cancer Alliance2004

Departments & Organizations